# Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Study · id `cardio:ct-nct01742611` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01742611](<https://clinicaltrials.gov/study/NCT01742611>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01742611

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT01742611. Allocation not applicable; no masking; primary purpose treatment. Start 2013-03 (registry gives no type); primary completion 2015-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT01742611, source copy `cardio:ctgov-nct01742611-2015-06-09`, retrieved 2026-10-26)
- Start date: 2013-03 (registry gives no type) (ClinicalTrials.gov record NCT01742611, source copy `cardio:ctgov-nct01742611-2015-06-09`, retrieved 2026-10-26)
- Primary completion: 2015-04 (actual) (ClinicalTrials.gov record NCT01742611, source copy `cardio:ctgov-nct01742611-2015-06-09`, retrieved 2026-10-26)
- Completion: 2015-04 (actual) (ClinicalTrials.gov record NCT01742611, source copy `cardio:ctgov-nct01742611-2015-06-09`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01742611, source copy `cardio:ctgov-nct01742611-2015-06-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01742611-2015-06-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
- Condition: Chronic Kidney Disease
- Condition: Renal Insufficiency
- Condition: Hyperphosphatemia
- Intervention (Drug): ASP1585
- Lead sponsor: Astellas Pharma Inc
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Astellas Pharma Inc (`cardio:org-astellas-pharma-inc`)

## Provenance

Content hash: c612473a3f1a6a7b51c1a23d5c966b2f48326d05c907e75fda6b100598ad688b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
